Literature DB >> 19538296

The tight junction protein ZO-2 blocks cell cycle progression and inhibits cyclin D1 expression.

Lorenza Gonzalez-Mariscal1, Rocio Tapia, Miriam Huerta, Esther Lopez-Bayghen.   

Abstract

ZO-2 is an adaptor protein of the tight junction that belongs to the MAGUK protein family. ZO-2 is a dual localization protein that in sparse cultures is present at the cell borders and the nuclei, whereas in confluent cultures it is concentrated at the cell boundaries. Here we have studied whether ZO-2 is able to regulate the expression of cyclin D1 (CD1) and cell proliferation. We have demonstrated that ZO-2 negatively regulates CD1 transcription by interacting with c-Myc at an E box present in CD1 promoter. We have further found that ZO-2 transfection into epithelial MDCK cells triggers a diminished expression of CD1 protein and decreases the rate of cell proliferation in a wound-healing assay.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19538296     DOI: 10.1111/j.1749-6632.2009.04024.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  10 in total

Review 1.  Tight junctions in the testis: new perspectives.

Authors:  Dolores D Mruk; C Y Cheng
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-05-27       Impact factor: 6.237

2.  Cooperation between HNF-1alpha, Cdx2, and GATA-4 in initiating an enterocytic differentiation program in a normal human intestinal epithelial progenitor cell line.

Authors:  Yannick D Benoit; Fréderic Paré; Caroline Francoeur; Dominique Jean; Eric Tremblay; François Boudreau; Fabrice Escaffit; Jean-François Beaulieu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-02-04       Impact factor: 4.052

Review 3.  The Mammalian Blood-Testis Barrier: Its Biology and Regulation.

Authors:  Dolores D Mruk; C Yan Cheng
Journal:  Endocr Rev       Date:  2015-09-10       Impact factor: 19.871

Review 4.  Tight junction proteins: from barrier to tumorigenesis.

Authors:  E Aaron Runkle; David Mu
Journal:  Cancer Lett       Date:  2013-06-03       Impact factor: 8.679

5.  CREB1 contributes colorectal cancer cell plasticity by regulating lncRNA CCAT1 and NF-κB pathways.

Authors:  Bin Li; Lisi Zheng; Jiayi Ye; Chenmin Zhang; Jie Zhou; Qiaojuan Huang; Yanhua Guo; Luqin Wang; Peng Yu; Shurong Liu; Qiao Lin; Yuxia Luo; Hui Zhou; Jianhua Yang; Lianghu Qu
Journal:  Sci China Life Sci       Date:  2022-06-10       Impact factor: 10.372

6.  The elements of human cyclin D1 promoter and regulation involved.

Authors:  Zhi-Yi Guo; Xiao-Hui Hao; Fei-Fei Tan; Xin Pei; Li-Mei Shang; Xue-Lian Jiang; Fang Yang
Journal:  Clin Epigenetics       Date:  2011-02-11       Impact factor: 6.551

7.  Gene and isoform expression signatures associated with tumor stage in kidney renal clear cell carcinoma.

Authors:  Qi Liu; Shilin Zhao; Pei-Fang Su; Shyr Yu
Journal:  BMC Syst Biol       Date:  2013-12-09

Review 8.  "You Shall Not Pass"-tight junctions of the blood brain barrier.

Authors:  Hans-Christian Bauer; István A Krizbai; Hannelore Bauer; Andreas Traweger
Journal:  Front Neurosci       Date:  2014-12-03       Impact factor: 4.677

9.  LAST, a c-Myc-inducible long noncoding RNA, cooperates with CNBP to promote CCND1 mRNA stability in human cells.

Authors:  Limian Cao; Pengfei Zhang; Jinming Li; Mian Wu
Journal:  Elife       Date:  2017-12-04       Impact factor: 8.140

10.  ZO-2 silencing induces renal hypertrophy through a cell cycle mechanism and the activation of YAP and the mTOR pathway.

Authors:  Alaide Domínguez-Calderón; Antonia Ávila-Flores; Arturo Ponce; Esther López-Bayghen; José-Víctor Calderón-Salinas; José Luis Reyes; Bibiana Chávez-Munguía; José Segovia; Carla Angulo; Leticia Ramírez; Helios Gallego-Gutiérrez; Lourdes Alarcón; Dolores Martín-Tapia; Pablo Bautista-García; Lorenza González-Mariscal
Journal:  Mol Biol Cell       Date:  2016-03-23       Impact factor: 4.138

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.